As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
-
-
Phytochemical profiling and GC-MS analysis of aqueous methanol fraction of Hibiscus asper leaves
-
Isolation, identification, and cytotoxicity evaluation of phytochemicals from chloroform extract of Spathodea campanulata
-
Development, optimization and characterization of flurbiprofen matrix transdermal drug delivery system using Box–Behnken statistical design
-
Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance
-
Recent advances in mesalamine colonic delivery systems
-
Ultra-high performance liquid chromatography-MS/MS (UHPLC-MS/MS) in practice: analysis of drugs and pharmaceutical formulations
-
Formulation, in-vitro and in-vivo pharmacokinetic evaluation of simvastatin nanostructured lipid carrier loaded transdermal drug delivery system
-
Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach
-
Exploring different approaches to improve the success of drug discovery and development projects: a review
About the Society
Future Journal of Pharmaceutical Sciences is the official Journal of the Future University in Egypt. Future University in Egypt (FUE) is a multidisciplinary University established in accordance to the presidential decree no 254 on 2006. It is dedicated to providing quality education, scholarly research and socially responsible public service to the community. FUE comprises six faculties among them, in special position, the Faculty of Pharmaceutical Sciences and Pharmaceutical Industries (FPSPI) lies. FPSPI is accredited by the National Authority for Quality Assurance and Accreditation of Education (NAQAAE).
Future University in Egypt is an educational institute committed to distinction, innovation and quality standards. FUE’s priority is to stay abreast with the national, regional and international changes taking place in the interrelated fields of education, scientific research and community development, while consolidating values and professional ethics.
Aims and scope
Future Journal of Pharmaceutical Sciences (FJPS) is the official journal of the Future University in Egypt. It is a peer-reviewed, open access journal which publishes original research articles, review articles and case studies on all aspects of pharmaceutical sciences and technologies, pharmacy practice and related clinical aspects, and pharmacy education. The journal publishes articles covering developments in drug absorption and metabolism, pharmacokinetics and dynamics, drug delivery systems, drug targeting and nano-technology. It also covers development of new systems, methods and techniques in pharmacy education and practice. The scope of the journal also extends to cover advancements in toxicology, cell and molecular biology, biomedical research, clinical and pharmaceutical microbiology, pharmaceutical biotechnology, medicinal chemistry, phytochemistry and nutraceuticals.
About the Editor
Professor Osama Salama is Vice President of Future University in Egypt (FUE), which is based in Cairo. He received his PHD in Natural Sciences and Phytochemistry (Dr. rer. nat) from the Institute of Pharmacy, Eidgenössische Technische Hochschule, Zürich, (ETHZ) Switzerland. He is a professor in Phytochemistry and the founder Dean for Faculty of Pharmaceutical Sciences and Pharmaceutical Industries atFUE. His experience includes academia and industry. Professor Salama spent about 20 years in research and development (R&D) and quality control (QC) for pharmaceutical drugs. His experience covers pharmaceutical development, preclinical development, clinical trials supplies and regulatory affairs. He has supervised and participated in innovation of two novel drugs for treatment of Schistosomiasis and Fasciolcasis and HCV. He has published about 100 research papers in national and international journals.
Affiliated with
-
Future Journal of Pharmaceutical Sciences is affiliated with Future University in Egypt.
- ISSN: 2314-7253 (electronic)
